(46) developed a urinary exosome-derived lncRNA panel consisting of MALAT1, PCAT-1, and SPRY4-IT1 for diagnosing bladder cancer, demonstrating high diagnostic accuracy compared to urine cytology. This evidence concerns the gene PCAT1 and urinary bladder cancer.